NeuroHope Therapeutics
Greenville
About NeuroHope Therapeutics
NeuroHope Therapeutics created an innovation that combines nanotechnology and medication and gene delivery. NeuroHope Therapeutics primary application is for central nervous system regeneration and repair.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $75.0K
- Last round: Grant (Dec 2025)
- Website: neurohopetherapeutics.com
Industries & Categories
Health Care, Medical, Personal Health
Canonical: https://fsome.com/organization/neurohope-therapeutics-45963 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.